The Access Industries and Eli Lilly-backed genetic drug developer floated at the top of its range having increased the number of shares in the offering by 60%.

Takeda has bought UW spinout PvP Biologics, three years after acquiring an option to buy it in return for $35m in financing.

Nottingham-founded Excellerate Biosciences has been bought by Oxford's spinout OMass Therapeutics, which unveiled a series A extension last week.

Takeda has bought celiac disease therapy developer PvP Biologics, three years after acquiring an option to buy it in return for $35m in financing.

CRM app developer Vlocity had received $163m from investors including Salesforce itself as well as fellow corporates New York Life and Accenture.

CapitalG, which first invested in the credit management platform at a sub-$1bn valuation, will exit in a $7.1bn purchase by Intuit.

Green Hill Partners has picked up insurance payment processor One, which counted Axa, American Family and MassMutual among its backers.

Quintillion Media has exited vehicle auction marketplace operator BlueJack in an acquisition of undisclosed size by peer Shriram Automall.

McKinsey has bought UVC Partners-backed Orpheus to implement a new service using the company's spending analytics technology.

Henkel, Robert Bosch and Rocket Internet have exited the on-demand laundry service Laundrapp in an acquisition by Inc & Co.